HCA
HCA HealthcareBNYSE / Health Care Equipment & Services
Last Price
At close
2026-07-18
Current thesis
Scale, improved payer mix and effective cost control — plus successful M&A or capital returns — could drive valuation toward the analyst high (560.0).
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.9.
What can break
CMS/Medicare reimbursement reductions
Momentum
16
Value
69
Sentiment
72
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $490.41 · Bull $560.00 · Bear $420.00
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-28 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $476.65
Why
Momentum16 · Δ7d +2.1
Value69 · Δ7d +0.9
Sentiment72 · Δ7d +7.5
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
16
26% active weight
Current posture
7d trendImproving
Δ7d
+2.1
Δ21d
+12.8
Value
69
39% active weight
Current posture
7d trendFlat
Δ7d
+0.9
Δ21d
+0.5
Sentiment
72
34% active weight
Current posture
7d trendImproving
Δ7d
+7.5
Δ21d
+5.9
Why this grade
Composite grade B. Momentum 15.9 / Value 68.9 / Sentiment 72.4
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$82.34B
Beta
1.37
Shares Out
221.84M
P/E (TTM)
18.5
P/S (TTM)
1.47
P/FCF (TTM)
14.71
Rev YoY
+4.3%
EPS YoY
+10.7%
Gross Margin
+15.7%
Op Margin
+15.6%
Net Debt
$47.55B
Current Ratio
0.83
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology